Healthtech Startups

ZETA Surgical makes a cranial navigation system for neurosurgical procedures including ventriculostomy, brain biopsy, and transcranial magnetic stimulation in operating rooms and interventional suites. The company serves neurosurgeons and healthcare systems.

6 investors

J-Pharma is a drug development company focused on SLC transporter-targeted therapies, with its lead LAT1 inhibitor nanvuranlat (JPH203) in a global Phase 3 trial for biliary tract cancer and other candidates addressing cancer, autoimmune, and rare diseases. The Tokyo-based biotech develops innovative small-molecule drugs and is listed on the Tokyo Stock Exchange Growth Market.

6 investors

1upHealth provides a FHIR-first health data platform that helps health plans and payers acquire, manage, and exchange healthcare data, including automating prior authorization, member data access, and provider directories. It supports interoperability and compliance with CMS regulations across Medicare, Medicaid, and commercial lines of business in the U.S.

5 investors

410 Medical makes LifeFlow, a hand-operated rapid infuser that lets clinicians quickly deliver blood or fluids to critically ill patients needing volume resuscitation. The device is aimed at hospital and emergency care settings for fluid resuscitation workflows.

5 investors

64x develops infrastructure and manufacturing systems for next-generation medicines, focusing on genetic engineering, cell line development, and computational biology to enable scalability of advanced therapies.

5 investors

AbleTo provides in-person and virtual mental health care, including therapy, psychiatry, and medication management for adults, children, and teens dealing with concerns such as anxiety, depression, ADHD, and substance use. It operates 150+ locations across the United States with over 1,200 therapists and psychiatrists, and accepts most insurance plans.

5 investors

Accent Therapeutics is a biotechnology company focused on discovering and developing small molecule drugs to improve health outcomes for cancer patients. It operates in oncology-focused drug discovery and development.

5 investors

Acto provides a mobile app platform for field-based sales teams in regulated industries to deliver training, coaching, and presentations with approved content and messaging. The solution includes keyword search, knowledge tracking via surveys, and push notification alerts for content updates.

5 investors

Adaptimmune Therapeutics is a biotechnology company, though the specific focus of their therapeutic work is not detailed on this investors and media page.

5 investors

Adaptyv Bio develops technologies for protein engineering that enable the design and testing of new proteins for applications in medicine, industrial enzymes, and functional materials. The company serves protein engineers and researchers developing therapeutic and industrial biological products.

5 investors

AdvanCell is a clinical-stage radiopharmaceutical company developing a pipeline of targeted alpha therapies for the treatment of cancers including prostate, melanoma, ovarian, breast, and lung. Its lead-212-based programs, such as ADVC001 for metastatic prostate cancer, are in clinical development.

5 investors

Adyn uses large inclusive datasets and machine learning to advance personalized medicine for historically under-researched health conditions, with initial focus on reproductive disorders. The company aims to close race and gender knowledge gaps in medical research.

5 investors

Aerie Pharmaceuticals develops ophthalmic pharmaceutical products including Rocklatan and Rhopressa for glaucoma and ocular hypertension, and AR-15512 for dry eye disease. The company serves eye care professionals and patients in the global ophthalmic pharmaceutical market.

5 investors

Aether Biomedical develops the Zeus multi-articulating bionic hand and an ecosystem of prosthetic devices, control systems, and connected digital tools. Its products serve upper-limb prosthetic users and the clinicians who fit and support them.

5 investors

Affect Therapeutics operates an app-based digital treatment provider offering care for substance use disorders (alcohol, cannabis, opioid) and mental health conditions like depression and anxiety, using methods such as contingency management, CBT, medication-assisted treatment, and peer support. It serves members across the U.S. including those covered by Medicaid, and works with providers, courts, employers, and health systems.

5 investors

Owkin develops AI Scientist, an autonomous AI system that uses biological large language models and multimodal patient data to accelerate drug discovery for pharmaceutical and biotech companies. The company aims to automate early-stage R&D and compress decades of discovery timelines into years.

5 investors

Aidaly runs a software-powered home care agency that trains and pays family members to become long-term care providers, helping them check eligibility and turn caregiving into paid work. It serves family caregivers in U.S. states including Florida, Arizona, Michigan, and Colorado.

5 investors

Akouos is a precision genetic medicine company developing therapies for the inner ear to restore, improve, and preserve hearing. It focuses on treating the underlying causes of hearing loss, including genetic hearing loss.

5 investors

Alector develops therapies targeting neurodegenerative diseases including Alzheimer's, frontotemporal dementia, and Parkinson's disease through protein removal, replacement, and immune cell restoration. The company focuses on patients with neurodegenerative conditions and applies genetics, neuroscience, and immunology to advance new treatments.

5 investors

Alice is a Brazilian corporate health plan (plano de saúde empresarial) for companies, combining a curated network of doctors and hospitals with an app-based care team and a data-driven, proactive care model. It serves employers and their employees, offering coordinated care, in-app health support, and HR-focused implementation.

5 investors

Alimetry develops the Gastric Alimetry system, a non-invasive body surface gastric mapping device that provides objective diagnostics for patients with chronic gastrointestinal symptoms. It is used by hospitals and GI clinicians, with availability in New Zealand, Australia, the UK, and the US.

5 investors

Alljoined develops neural decoding technology using machine learning to enable computers to interpret human brain activity, aiming to enhance human capability, mental health, and interpersonal understanding. The company applies computational neuroscience to brain-computer interfaces for research and practical applications.

5 investors

Amarin Corporation is a cardiovascular health pharmaceutical company developing treatments to prevent cardiovascular disease. The company focuses on pharmaceutical development and clinical research in the cardiovascular health sector.

5 investors

AMBOSS is a digital medical knowledge platform serving doctors, medical students, and healthcare professionals worldwide with study materials, clinical reference content, and exam preparation tools. The platform serves over one million users across more than 180 countries and has been adopted by major medical schools and hospital networks.

5 investors